T 0039/23 of 16.05.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T003923.20240516
- Date of decision
- 16 May 2024
- Case number
- T 0039/23
- Petition for review of
- -
- Application number
- 18157435.1
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- CRYSTALLINE FORMS OF AN ANDROGEN RECEPTOR MODULATOR
- Applicant name
- Aragon Pharmaceuticals, Inc.
Sloan-Kettering Institute for Cancer Research - Opponent name
- SANDOZ AG
Scorpio IP Limited - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by the patent proprietors
- Catchword
- -
- Cited cases
- T 0073/84
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.